Secondary EGFR Mutations and MET Amplification Underlying Osimertinib Resistance in Advanced Non–Small Cell Lung Cancer: A PRISMA-Compliant Systematic Review and Pooled Analysis
Crossref DOI link: https://doi.org/10.18081/ajbm.2026.3.246
Published Online: 2026-09-30
Update policy: https://doi.org/10.18081/ajbm/2025.0/001
Ghaly Yousif, Nasser
